- GBP/USD keeps a downside break of monthly support line, eyes further weakness.
- Hopes of regulatory approval to leading covid vaccines battle Brexit jitters.
- EU’s Barnier reaches London, UK PM Johnson is likely to be approached by the bloc’s leader.
GBP/USD trims monthly gains while declining in the last week to re-test 1.3300. The pair awaits the Asian session’s reaction to the latest news concerning Brexit and the covid vaccine on early Monday. Although broad US dollar weakness and hopes concerning the coronavirus (COVID-19) vaccine have mainly propelled the Cable during November, bulls are turning cautious off-late as Brexit uncertainty weighs.
Pfizer, AstraZeneca gains UK’s back-up, Brexit still in limbo…
During the weekend the Financial Times (FT) came out with the news suggesting that the UK’s medical regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), is set to approve Pfizer-BioNTech coronavirus vaccine from December 7. The news follows the previous chatters that the British government is pushing MHRA to approve AstraZeneca’s covid vaccine. Elsewhere, the FT also claimed that the European Medicines Agency is set to consider next month whether to approve Pfizer/BioNTech vaccine and a rival candidate developed by Moderna.
Read: UK set to approve Pfizer-BioNTech coronavirus vaccine from December 7 – FT
Hence, vaccine hopes are on full stream at a time when the market needs it the most, especially when the UK’s economy is already fragile with two national lockdowns.
On the other hand, Brexit talks continue to dwindle. After much hype, the European Union’s (EU) Chief Negotiator Michel Barnier landed in London for a one-to-one talk. However, nothing strong has come out as both the parties blame each other for the deadlock. Fisheries have recently been the major hurdle. Chatters also crossed grapevine that talks could be held between European Commission President Ursula von der Leyen and UK PM Boris Johnson. However, nothing could be confirmed by the UK PM Johnson’s office.
Over the counter, US dollar weakness, mainly led by the market optimism concerning vaccine and Joe Biden’s election as the President, probe the GBP/USD bears.
Moving on, the pair traders will keep their eyes on the risk events, mainly concerning the Brexit and virus vaccine, for fresh impulse. Though, US dollar moves will also be the key to watch.
Technical analysis
A clear downside break of an ascending trend line from November 02, at 1.3385 now, directs GBP/USD bears toward October high near 1.3175. Alternatively, the monthly high near 1.3400 adds to the upside filters.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD alternates gains with losses near 1.0720 post-US PCE
The bullish tone in the Greenback motivates EUR/USD to maintain its daily range in the low 1.070s in the wake of firmer-than-estimated US inflation data measured by the PCE.
GBP/USD clings to gains just above 1.2500 on US PCE
GBP/USD keeps its uptrend unchanged and navigates the area beyond 1.2500 the figure amidst slight gains in the US Dollar following the release of US inflation tracked by the PCE.
Gold keeps its daily gains near $2,350 following US inflation
Gold prices maintain their constructive bias around $2,350 after US inflation data gauged by the PCE surpassed consensus in March and US yields trade with slight losses following recent peaks.
Bitcoin Weekly Forecast: BTC’s next breakout could propel it to $80,000 Premium
Bitcoin’s recent price consolidation could be nearing its end as technical indicators and on-chain metrics suggest a potential upward breakout. However, this move would not be straightforward and could punish impatient investors.
Week ahead – Hawkish risk as Fed and NFP on tap, Eurozone data eyed too
Fed meets on Wednesday as US inflation stays elevated. Will Friday’s jobs report bring relief or more angst for the markets? Eurozone flash GDP and CPI numbers in focus for the Euro.